Deutsche Bank Ag\ Bei Gene, Ltd. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 744 shares of BGNE stock, worth $144,529. This represents 0.0% of its overall portfolio holdings.

Number of Shares

744

Previous 5,684 86.91%

Holding current value

$144,529

Previous $810,000 79.38%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$143.93 - $224.51 $711,014 - $1.11 Million	-4,940 Reduced 86.91%	744 $167,000
Q2 2024 Aug 14, 2024	BUY	$129.52 - $174.32 $95,974 - $129,171	741 Added 14.99%	5,684 $810,000
Q1 2024 May 15, 2024	SELL	$141.8 - $181.47 $1.41 Million - $1.81 Million	-9,975 Reduced 66.87%	4,943 $773,000
Q4 2023 Feb 14, 2024	SELL	$158.67 - $201.58 $744,003 - $945,208	-4,689 Reduced 23.91%	14,918 $2.69 Million
Q3 2023 Nov 09, 2023	SELL	$179.87 - $225.13 $313,513 - $392,401	-1,743 Reduced 8.16%	19,607 $3.53 Million
Q2 2023 Aug 14, 2023	SELL	$178.3 - $266.78 $2.48 Million - $3.72 Million	-13,929 Reduced 39.48%	21,350 $3.81 Million
Q1 2023 May 15, 2023	SELL	$215.53 - $274.5 $3,664 - $4,666	-17 Reduced 0.05%	35,279 $7.6 Million
Q4 2022 Feb 13, 2023	SELL	$125.51 - $229.3 $8.18 Million - $14.9 Million	-65,189 Reduced 64.87%	35,296 $7.76 Million
Q3 2022 Nov 14, 2022	SELL	$131.8 - $202.24 $36,508 - $56,020	-277 Reduced 0.27%	100,485 $13.5 Million
Q2 2022 Aug 11, 2022	SELL	$121.11 - $216.05 $188,204 - $335,741	-1,554 Reduced 1.52%	100,762 $16.3 Million
Q1 2022 May 13, 2022	SELL	$146.52 - $269.56 $1.89 Million - $3.47 Million	-12,879 Reduced 11.18%	102,316 $19.3 Million
Q4 2021 Feb 11, 2022	BUY	$248.56 - $389.34 $1.18 Million - $1.85 Million	4,755 Added 4.31%	115,195 $31.2 Million
Q3 2021 Nov 04, 2021	BUY	$249.6 - $403.14 $7.08 Million - $11.4 Million	28,346 Added 34.53%	110,440 $40.1 Million
Q2 2021 Aug 11, 2021	BUY	$292.75 - $367.01 $661,029 - $828,708	2,258 Added 2.83%	82,094 $28.2 Million
Q1 2021 May 13, 2021	BUY	$260.64 - $382.12 $1.13 Million - $1.65 Million	4,322 Added 5.72%	79,836 $27.8 Million
Q4 2020 Feb 16, 2021	SELL	$221.31 - $316.61 $3.78 Million - $5.41 Million	-17,079 Reduced 18.45%	75,514 $19.5 Million
Q3 2020 Nov 12, 2020	SELL	$189.18 - $286.44 $1.74 Million - $2.64 Million	-9,202 Reduced 9.04%	92,593 $26.5 Million
Q2 2020 Aug 13, 2020	BUY	$123.9 - $195.41 $3.55 Million - $5.6 Million	28,662 Added 39.19%	101,795 $19.2 Million
Q1 2020 May 14, 2020	SELL	$121.84 - $173.19 $9.5 Million - $13.5 Million	-77,987 Reduced 51.61%	73,133 $9 Million
Q4 2019 Feb 14, 2020	SELL	$115.78 - $208.34 $180,616 - $325,010	-1,560 Reduced 1.02%	151,120 $25 Million
Q3 2019 Nov 14, 2019	SELL	$120.61 - $148.29 $26.8 Million - $32.9 Million	-221,929 Reduced 59.24%	152,680 $18.7 Million
Q2 2019 Aug 14, 2019	BUY	$113.99 - $146.86 $10.5 Million - $13.5 Million	92,003 Added 32.56%	374,609 $46.4 Million
Q1 2019 May 15, 2019	BUY	$122.82 - $151.83 $3.76 Million - $4.64 Million	30,577 Added 12.13%	282,606 $37.3 Million
Q4 2018 Feb 14, 2019	SELL	$107.01 - $175.15 $8.94 Million - $14.6 Million	-83,546 Reduced 24.9%	252,029 $35.3 Million
Q3 2018 Dec 21, 2021	BUY	$152.62 - $189.66 $818,348 - $1.02 Million	5,362 Added 1.62%	335,575 $57.8 Million
Q3 2018 Nov 14, 2018	SELL	$152.62 - $189.66 $6.75 Million - $8.39 Million	-44,229 Reduced 11.81%	330,213 $56.9 Million
Q2 2018 Apr 21, 2020	BUY	$152.5 - $216.77 $729,865 - $1.04 Million	4,786 Added 1.29%	374,442 $57.6 Million
Q2 2018 Aug 14, 2018	BUY	$152.5 - $216.77 $22.7 Million - $32.3 Million	148,782 Added 67.36%	369,656 $56.8 Million
Q1 2018 Oct 18, 2019	BUY	$97.41 - $177.22 $331,875 - $603,788	3,407 Added 1.57%	220,874 $37.1 Million
Q1 2018 May 15, 2018	BUY	$97.41 - $177.22 $745,478 - $1.36 Million	7,653 Added 3.65%	217,467 $36.5 Million
Q4 2017 Feb 14, 2018	SELL	$79.6 - $114.73 $2.05 Million - $2.95 Million	-25,735 Reduced 10.93%	209,814 $20.5 Million
Q3 2017 Nov 14, 2017	BUY	$66.19 - $103.46 $15.6 Million - $24.4 Million	235,549	235,549 $24.4 Million

Others Institutions Holding BGNE

# of Institutions

249

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $20.1B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account